期刊
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
卷 142, 期 12, 页码 2447-2459出版社
SPRINGER
DOI: 10.1007/s00432-016-2249-6
关键词
Fatty acid synthase; Glioma stem cells; Neovascularization; Vascular endothelial growth factor A
类别
资金
- National Natural Science Foundation of China [81372354, 81302186]
- Beijing Municipal Natural Science Foundation [7151002]
- Beijing Health System High-level Personnel Building Foundation [2013-3-018]
- Beijing Laboratory of Biomedical Materials Foundation [PXM2014_014226_000005]
- Beijing Municipal Administration of Hospitals' Youth Program [QML20150505]
Fatty acids (FAs) are essential for membrane lipids biosynthesis and energy consumption in cancer cells. De novo FAs synthesis is catalyzed by fatty acid synthase (FASN), which is overexpressed and correlates with histological grade in glioma. Herein, we focused on the role of FASN in glioma neovascularization. The expression levels of FASN, Ki67 and CD34 were determined using immunohistochemistry (IHC). FASN specific-targeted shRNA and C75 were applied to evaluate the influence of FASN on glioma stem cell proliferation, migration and tube formation ability in vitro. An intracranial glioma model was established to study the effects of FASN on tumor growth and neovascularization in vivo. IHC staining showed that the expression level of FASN correlated with tumor grade, Ki67 levels and microvessels density (MVD) in human gliomas. Inhibition of FASN using shRNAs or C75 decreased tumor growth, prolonged the overall survival of xenograft mice and decreased MVD in brain tumor sections. Moreover, inhibition of FASN blocked hypoxia-inducible factor-1 alpha (HIF-1 alpha)/vascular endothelial growth factor A (VEGF-A) signaling and upregulated the anti-angiogenic isoform-VEGF(165)b. Our results suggest that FASN plays a pivotal role in glioma neovascularization, and inhibition of FASN may be a potential target for anti-angiogenic therapy for glioma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据